|
|
Win the Room! Updates in Interstitial Lung Disease...
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
Clinical Issues in Severe Asthma: Debates and Disc...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
Real World Impact in IPF: How to Make System Level...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
Type 2 Inflammation in Asthma: Defining Features a...
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
Recent evidence in the treatment of COPD: an inter...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
Treating Adults with Uncontrolled Severe Eosinophi...
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
Exploring Eosinophilic Granulomatosis with Polyang...
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
Redefining the Approach to Asthma and COPD: A New ...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
Emerging European PAH Registry Data: Risk Assessme...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
Update on the Treatment of Sarcoidosis: Results of...
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
Consider the Risk: A Case-based Look at Risk Asses...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
How Are We Diagnosing and Managing Our Patients Wi...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
The Future of Pneumonia Diagnostics: How Multiplex...
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
Optiflow™ Nasal High Flow Evidence and Equipoise
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
Uncovering a Genetic Cause of COPD: Alpha1-antitry...
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
Advanced Sarcoidosis: Who is at risk?
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
Idiopathic Pulmonary Fibrosis: From Presentation t...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
|
|
Compete and Win! Pulmonary Hypertension at the Cro...
Tuesday, May 226:30 PM - 9:30 PM
|
|
|
|
|
New Therapies, New Opportunities and New Challenge...
Sunday, May 206:30 PM - 9:30 PM
|
|
|
Home
Inbox
Search